
No data
No data
No data
| CAS Number | 206361-99-1 |
| Catalog Number | AG007QUW(AGN-PC-0QW0D2) |
| Chemical Name | Darunavir |
| EC Number | 606-590-1 |
| IUPAC Name | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate |
| InChI | InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1 |
| InChI Key | CJBJHOAVZSMMDJ-HEXNFIEUSA-N |
| MDL Number | MFCD09260006 |
| Molecular Formula | C27H37N3O7S |
| Molecular Weight | 547.6636 |
| SMILES | NC1=CC=C(C=C1)S(=O)(=O)N(C[C@H]([C@H](CC1=CC=CC=C1)NC(O[C@H]1CO[C@H]2OCC[C@H]21)=O)O)CC(C)C |
| UNII | YO603Y8113 |
| Synonyms | 114, TMC,
darunavir,
darunavir ethanolate,
Ethanolate, Darunavir,
Prezista,
TMC 114,
TMC-114,
TMC114,
UIC 94017,
UIC-94017,
UIC94017,
Darunavir,
206361-99-1,
TMC114,
Prezista,
TMC-114,
UIC-94017,
Darunavirum,
TMC 114,
Darunavirum [INN-Latin],
UNII-YO603Y8113,
AIDS073035,
CHEMBL1323,
(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE,
CHEBI:367163,
Darunavir-d9,
MFCD09260006,
YO603Y8113,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate,
NCGC00168773-01,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate,
N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide,
Darunavir [USAN],
Prezista(TM),
UIC 94017,
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate,
Darunavir (USAN/INN),
Darunavir [USAN:INN:BAN],
Prezista Naive,
HSDB 7788,
2idw,
2ien,
3bvb,
3cyw,
3ekt,
3ggu,
3lzs,
3lzu,
3lzv,
3ogp,
3pwm,
3qoz,
3tkw,
3ttp,
4hla,
Darunavir (DRV),
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate,
TMC41629,
TMC 41629,
UIC-96017,
2f8g,
2hs1,
2hs2,
3d1z,
3so9,
3t3c,
3u7s,
4ll3,
DRV & AAG,
DRV & HSA,
AC1L4U4V,
DSSTox_CID_26779,
DSSTox_RID_81898,
DSSTox_GSID_46779,
(3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester,
SCHEMBL118546,
BDBM8125,
UIC-940T,
Darunavir & human serum albumin,
Darunavir, >=98% (HPLC),
DTXSID0046779,
CTK8E7239,
2f80,
2f81,
3d20,
3s53,
3s54,
CJBJHOAVZSMMDJ-HEXNFIEUSA-N,
HMS3715I13,
ZINC3955219,
Tox21_112634,
Darunavir & alpha1-acid glycoprotein,
MC-114,
AKOS015966592,
AN-1069,
API0000506,
BCP9000587,
CS-0749,
DB01264,
KS-1469,
RTX-013373,
SB17490,
(3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate,
(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate,
(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate,
[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester,
{(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester,
AC-26778,
BC677684,
Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester,
HY-17040,
BCP0726000058,
AB0032516,
LS-187026,
LS-187772,
LS-191295,
CAS-206361-99-1,
ST24046418,
X5831,
D03656,
W-5398,
AB01565837_02,
361D991,
J-013483,
((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-carbamic acid (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester,
(3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(sup 1)-isobutylsulfanilamido)propyl)carbamate,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate,
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate,
[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]-furan-3-yl ester,
Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester,
Darunavir ethanolate,
darunavir ethnolate,
Darunavir [INN],
Prezista (TN),
Ethanolate, Darunavir,
Darunavir and cobicistat,
Darunavir [USAN:INN],
D01WFC,
D03IGH,
C27H37N3O7S,
114, TMC,
UIC94017,
C27-H37-N3-O7-S,
CID213039,
CS-O-00249,
GS-9350,
A8206,
C482292,
D000069454,
635728-49-3,
1133378-37-6,
618109-00-5,
DRV,
|
| Complexity | 853 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 547.235g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 38 |
| Hydrogen Bond Acceptor Count | 9 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 547.667g/mol |
| Monoisotopic Mass | 547.235g/mol |
| Rotatable Bond Count | 12 |
| Topological Polar Surface Area | 149A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.9 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

